SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008980
Filing Date
2022-05-16
Accepted
2022-05-16 16:33:32
Documents
43
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpth-20220331x10q.htm   iXBRL 10-Q 591768
2 EX-10.1 bpth-20220331xex10d1.htm EX-10.1 10406
3 EX-31 bpth-20220331xex31.htm EX-31 12489
4 EX-32 bpth-20220331xex32.htm EX-32 6285
  Complete submission text file 0001558370-22-008980.txt   2328637

Data Files

Seq Description Document Type Size
5 EX-101.SCH bpth-20220331.xsd EX-101.SCH 25062
6 EX-101.CAL bpth-20220331_cal.xml EX-101.CAL 20880
7 EX-101.DEF bpth-20220331_def.xml EX-101.DEF 60210
8 EX-101.LAB bpth-20220331_lab.xml EX-101.LAB 174999
9 EX-101.PRE bpth-20220331_pre.xml EX-101.PRE 141701
37 EXTRACTED XBRL INSTANCE DOCUMENT bpth-20220331x10q_htm.xml XML 207120
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 22929901
SIC: 2834 Pharmaceutical Preparations